Recent political events have thrust the bulk negotiation of drug prices by Medicare and Medicaid back into the spotlight. Yet, even if politically feasible, there is no clear framework for negotiating prices of new drugs with uncertain target populations—for example, due to imprecise estimates...

This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...

We study the effects of balance billing, i.e., allowing physicians to charge a fee from patients in addition to the fee paid by Medicare. First, we show that on pure efficiency grounds the optimal Medicare fee under balance billing is zero. An active Medicare policy thus can only be justified...

This paper provides field evidence on (a) how price framing affects consumers' decision to switch health insurance plans and (b) how the price elasticity of demand for health insurance can be influenced by policymakers through simple regulatory efforts. In 2009, in order to foster competition...

Using SOEP panel data and difference-in-differences methods, this study is the first to empirically evaluate the effectiveness of four different health care cost containment measures within an integrated framework. The four measures investigated were introduced in Germany in 1997 to reduce moral...

The German health care reform implemented in 2009 led to a considerable increase in price transparency within the statutory health insurance (SHI) (Gesetzliche Krankenversicherung, GKV) system and also made it more consumer-friendly which, in turn, has encouraged policy holders to react to price...

This paper provides fi eld evidence on (a) how price framing aff ects consumers' decision to switch health insurance plans and (b) how the price elasticity of demand for health insurance can be influenced by policymakers through simple regulatory efforts. In 2009, in order to foster competition...

The main determinants of the financial problems of the German statutory health and longtermcare systems are demographic aging, the medical-technical progress as well as thedisproportionate cost increase in long-term care services. Concerning these factors, onlyreform concepts on the expenditure...

Seit einigen Jahren wird in Deutschland über Veränderungen in der Finanzierungund im Leistungskatalog des Krankenversicherungssystems intensiv diskutiert. Dabeiwerden häufig problematische Anreizstrukturen im Hinblick auf das Verhaltender Versicherten genannt. Insbesondere haben Versicherte...

A famous idea to maintain affordable health expenditures is to cut back statutory health insurance (SHI) to a basic insurance and to introduce supplementary private health insurance (PHI), permitted to cover the remaining benefits and to apply managed care mechanisms. The measure is supposed to...